Viratis

Viratis is a Swiss biotechnology company based in Basel that specializes in the development of next-generation antiviral therapies. The company focuses on host-targeting strategies, which aim to inhibit viral replication by modulating cellular pathways rather than targeting the virus directly, a method intended to minimize the risk of drug resistance. Its research is primarily directed toward treating severe respiratory viral infections, including COVID-19 and influenza. Founded by a group of seasoned life sciences entrepreneurs and investors, Viratis leverages a host-centered approach to provide broad-spectrum protection against emerging and mutating viral threats.